Recent

% | $
Quotes you view appear here for quick access.

Pernix Therapeutics Holdings, Inc. Message Board

  • zero.risk13 zero.risk13 Nov 12, 2013 11:47 AM Flag

    Switch to GTHP: Market Cap $40M: Cervical Cancer Scan Approved in Asia, EU, Canada.....

    Awaiting FDA approval.

    The biophotonics scan will replace 60 million annual PAP smears.
    It's more accurate, noninvasive and provides instantaneous test results.

    +++++++++++++++++++++++

 
PTX
4.92-0.25(-4.84%)3:06 PMEDT